Hyperactivity News and Research

RSS

Clay modelling could help disturbed teenagers deal with mental health problems

Researchers at The University of Nottingham are to investigate whether the therapeutic effects of clay modelling could help disturbed teenagers deal with their feelings of anger, anxiety and depression.

24 Aug 2011

Risk of depression in formerly depressed people

Depression is increasingly recognized as an illness that strikes repeatedly over the lifespan, creating cycles of relapse and recovery. This sobering knowledge has prompted researchers to search for markers of relapse risk in people who have recovered from depression. A new paper published in Elsevier's Biological Psychiatry suggests that when formerly depressed people experience mild states of sadness, the nature of their brains' response can predict whether or not they will become depressed again.

22 Aug 2011

Brain's reaction to sadness can predict risk of future depression

22 Aug 2011

More kids being diagnosed with ADHD

A new study revealed that number of children diagnosed with Attention Deficit Hyperactivity disorder or ADHD has risen sharply over the last decade.

18 Aug 2011

NIH study in mice shows potential new target for treatment of ADHD

A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.

17 Aug 2011

Scientists identify new therapeutic target for ADHD, other neuropsychiatric disorders

A biochemical pathway long associated with diarrhea and intestinal function may provide a new therapeutic target for treating ADHD other neuropsychiatric disorders, according to a team of scientists from China and the United States reporting Aug. 11 in Science.

12 Aug 2011

Mercury and autism link strengthened

The researchers from Swinburne University in Melbourne surveyed 522 Australian survivors of Pink disease - a form of mercury poisoning common in the early 20th century - found one in 25 of their 398 grandchildren aged six to 12 had an autism spectrum disorder.

10 Aug 2011

ADHD severity impacts child's health-related quality of life

The greater the severity of a child's Attention Deficit Hyperactivity Disorder (ADHD) symptoms, the more negative impacts on the child's health-related quality of life from the perspective of the child and the parent, a new study by a Baylor University psychologist has found.

28 Jul 2011

Amphetamines can control ADHD symptoms in adults

Giving amphetamines to adults with Attention Deficit Hyperactivity Disorder (ADHD) can help them control their symptoms, but the side effects mean that some people do not manage to take them for very long.

27 Jul 2011

Methamphetamine users more likely to develop Parkinson's disease

People who abused methamphetamine or other amphetamine-like stimulants were more likely to develop Parkinson's disease than those who did not, in a new study from the Centre for Addiction and Mental Health.

27 Jul 2011

Study explores factors for misuse of prescription opioid in young injection drug users

A new study by researchers at Drexel University's School of Public Health suggests that abuse of prescription painkillers may be an important gateway to the use of injected drugs such as heroin, among people with a history of using both types of drugs.

25 Jul 2011

Children with ADHD may face increased risk of pedestrian injury

Children with attention deficit/hyperactivity disorder (ADHD) are at increased risk of being hit by a vehicle when crossing a street, according to new research from the University of Alabama at Birmingham.

25 Jul 2011

Researchers discover novel combination of two mutations in a patient with ADHD

Often enough, in science as in life, unexpected knowledge has a personal impact. Researchers seeking rare gene variants in just a few individuals with attention-deficit hyperactivity disorder (ADHD) discovered that one patient had a novel combination of two mutations.

21 Jul 2011

Excess brain activity in aMCI patients contributes to brain dysfunction underlying memory loss

An existing anti-seizure drug improves memory and brain function in adults with a form of cognitive impairment that often leads to full-blown Alzheimer's disease, a Johns Hopkins University study has found.

21 Jul 2011

Exposure to tobacco smoke nearly doubles risk of hearing loss among adolescents

NYU School of Medicine researchers report in a new study that exposure to tobacco smoke nearly doubles the risk of hearing loss among adolescents. The study is published in the July, 2011, issue of Archives of Otolaryngology - Head & Neck Surgery.

19 Jul 2011

Ultrasound can detect risk of psychiatric disorders in premature infants

Infants born prematurely are at risk for injuries to the white and gray matter of the brain that affect cortical development and neural connectivity. Certain forms of these injuries can be detected in the neonatal period using ultrasound, according to Columbia University Medical Center researchers.

15 Jul 2011

Clinical symptoms of food addiction are similar to symptoms of drug addiction

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that people can become dependent on highly palatable foods and engage in a compulsive pattern of consumption, similar to the behaviors we observe in drug addicts and those with alcoholism.

13 Jul 2011

Secondhand smoke linked to ADHD, learning and behavioral disorders in kids

The latest study shows that secondhand (passive) smoke can contribute to Attention Deficit Hyperactivity Disorder (ADHD) and other learning disabilities in children. The study from the Harvard School of Public Health, shows kids exposed to smoking were 50 percent more likely to develop neurobiological diseases compared to kids not around smoke.

12 Jul 2011

Shire files lawsuit against Watson over generic Vyvanse

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market lisdexamfetamine dimesylate capsules. Watson's lisdexamfetamine dimesylate capsules are a generic version of Shire LLC's Vyvanse®.

8 Jul 2011

Non-invasive intervention can greatly improve patients' inhibitory control

Inhibitory control can be boosted with a mild form of brain stimulation, according to a study published in the June 2011 issue of Neuroimage, Elsevier's Journal of Brain Function.

16 Jun 2011